Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 4OTHER_GOV 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Head and Neck Neoplasms 3Melanoma 2Glioblastoma 2Brain Neoplasms 2Advanced Solid Tumor 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ulnar Neuropathies 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Prostatic Hyperplasia 1Peripheral Lung Tumor 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Non Squamous Lung Cancer 1Neuroma 1Multiple Myeloma 1Mucositis 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyoma 1Keratosis, Actinic 1Hyperthermia 1Glioma 1

Interventions

pembrolizumab 44Carboplatin 28Cisplatin 26Paclitaxel 24Bevacizumab 21human papillomavirus vaccine, L1 type 16, 18 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14atezolizumab 11Papillomavirus Vaccines 11Nivolumab 10tisotumab vedotin 8Vaccines, Synthetic 8Gemcitabine 8Colposcopy 8Topotecan 7fludarabine 6Vaccines 6Injections 6Cyclophosphamide 6spartalizumab 5balstilimab 5Pemetrexed 5Irinotecan 5Fulvestrant 5Docetaxel 5zimberelimab 4durvalumab 4Vinorelbine 4Ipilimumab 4Interleukin-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Neoplasms × Therapeutics × Clear all
NCT01851772 2021-01-12

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

Xoft, Inc.

Phase NA Completed
3 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡